摘要
目前恶性黑色素瘤(MM)主要的靶向治疗方法包括信号传导通路抑制剂、靶向凋亡、蛋白酶体抑制剂、抗血管生成治疗等。MM靶向治疗研究的发展方向是根据患者对靶向治疗敏感性的差异选择更加个体化的靶向治疗方法和技术。
Now, the main methods of targeted therapy for malignant melanoma (MM) include signal transduction pathway inhibitors, targeted apoptosis, proteasome inhibitors, antiangiogenic therapies. The devel- opment direction of the targeted therapy is to select more individualized methods and techniques according to the patients difference of sensitivity for targeted therapy.
出处
《国际肿瘤学杂志》
CAS
2009年第2期149-151,共3页
Journal of International Oncology